
Weight and metabolic · 3 min read
Enjoy the Colder Months Without the Weight Gain: How GLPs Can Help
Learn how GLPs injections support supervised winter weight loss. Discover how these therapies help manage appetite and maintain health year-round.
Summer body weight goals are great, but sometimes it's easy to lose momentum in the colder months. But it's still possible to make healthy weight loss a priority throughout the winter! GLPs injections are taking the weight loss market by storm, and they can help support your winter weight loss plan.
These medications are incredibly popular, and we prescribe them as part of a balanced weight loss plan under the guidance of a skilled medical provider, like Dr. Scott Faulkner at Castle Rock Regenerative Healthcare. We offer GLPs as part of Dr. Faulkner's tailored weight loss programs through appointments in person or by phone. Learn how both these treatments may support your weight loss goals this winter.
What Are GLPs?
Tirzepatide and Semaglutide are offered here as compounded preparations prescribed by your provider. Separately, the brand-name products Wegovy® and Zepbound® are FDA approved for weight management, and Ozempic® and Mounjaro® are FDA approved for type 2 diabetes. A compounded preparation is not itself FDA approved. Delivered as injectables, semaglutide and Tirzepatide were originally developed to support the management of type 2 diabetes. They have since been studied for weight management in people without diabetes as well.
How Do GLPs Work?
Both semaglutide and Tirzepatide work by delaying gastric emptying and affecting hunger hormones. They are administered as once-weekly injections into the abdominal tissue and have been studied in individuals with and without type 2 diabetes, and those with a small or large weight loss goal.
While semaglutide is a selective GLP-1 (Glucagon-Like Peptide-1) receptor agonist, Tirzepatide is both a GLP-1 and GIP (Glucose-Dependent Insulinotropic Polypeptide) agonist. A GLP-1 agonist controls appetite by mimicking the "I'm full" hormone, while tirzepatide's extra GIP factor is thought to strengthen this signal, and researchers are studying its effects on LDL cholesterol and triglyceride levels.
How Long After Starting Injections Do I Start Seeing Results?
Each person's weight loss journey is unique. Everyone responds differently. Also, GLPs studies have looked at these therapies as part of a long-term weight loss program.
While GLPs can be prescribed as standalone treatments, we recommend healthy lifestyle changes, as well. These include a healthy diet and exercise routine. Castle Rock Regenerative Healthcare is here to help you meet your regenerative health goals holistically with the guidance of our compassionate team of professionals.
What Kind Of Side Effects Could I Experience?
Some GI-related side effects are tied to Semaglutide and Tirzepatide, but many clients mainly notice a reduction in appetite. Symptoms may manifest if an individual is experiencing a dosage increase and can include nausea, diarrhea, heartburn, headaches, or constipation.
What Medication Is Best For Me This Winter?
GLPs are a popular option for people who want to lose weight or maintain weight loss any time of the year, not just during winter. Dr. Faulkner is a board-certified physician and trusted provider focused on advanced regenerative health. He creates unique weight loss plans to meet each individual's goals year-round.
At CRRH, we offer a free 30-minute consultation! Discuss your health goals and potential weight loss medications that are best for you. Both in-person and phone appointments are available here.
Keep your weight loss momentum through the dredges of the colder months with support from Castle Rock Regenerative Healthcare, where we love what we do and help you feel like "you."
Sources:
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
- Tirzepatide Once Weekly for the Treatment of Obesity
- Tirzepatide versus semaglutide Once Weekly in Patients with Type 2 Diabetes
- Tirzepatide: A Systematic Update
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- Once-Weekly semaglutide in Adults with Overweight or Obesity
- Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial
- Safety of semaglutide
- Effect of Continued Weekly Subcutaneous semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
Published . Medically reviewed by Scott Faulkner, MD, board certified in Internal Medicine. This article is educational and is not medical advice. Individual results vary.
Start with a conversation.
A free 30-minute consultation is the simplest first step. One of our providers answers your questions about the practice, cost and scheduling, and tells you whether it looks like a fit. You do not need labs or a paid visit to start.
